4.8 Article

Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer

Journal

NUCLEIC ACIDS RESEARCH
Volume 38, Issue 11, Pages 3619-3631

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkq084

Keywords

-

Funding

  1. Maryland Technology Corporation
  2. Department of Defense [W81XWH-07-0267]
  3. National Institutes of Health [R01 CA76047, R21 088882-01]
  4. Department of Pathology
  5. National Institutes of Health
  6. NATIONAL CANCER INSTITUTE [R01CA076047] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE ON AGING [ZIAAG000511] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Androgen receptor (AR)-mediated pathways play a critical role in the development and progression of prostate cancer. However, little is known about the regulation of AR mRNA stability and translation, two central processes that control AR expression. The ErbB3 binding protein 1 (EBP1), an AR corepressor, negatively regulates crosstalk between ErbB3 ligand heregulin (HRG)-triggered signaling and the AR axis, affecting biological properties of prostate cancer cells. EBP1 protein expression is also decreased in clinical prostate cancer. We previously demonstrated that EBP1 overexpression results in decreased AR protein levels by affecting AR promoter activity. However, EBP1 has recently been demonstrated to be an RNA binding protein. We therefore examined the ability of EBP1 to regulate AR post-transcriptionally. Here we show that EBP1 promoted AR mRNA decay through physical interaction with a conserved UC-rich motif within the 3'-UTR of AR. The ability of EBP1 to accelerate AR mRNA decay was further enhanced by HRG treatment. EBP1 also bound to a CAG-formed stem-loop in the 5' coding region of AR mRNA and was able to inhibit AR translation. Thus, decreases of EBP1 in prostate cancer could be important for the post-transcriptional up-regulation of AR contributing to aberrant AR expression and disease progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available